Lifespan Cancer Institute
- Types of Cancer
- Find a Physician by Specialty
- Schedule an Appointment
- Treatment Information
- Your Care Team
- Support and Rehabilitation
- Survivorship Program
- Awards and Certifications
- Patient and Family Advisory Council
- Patient Stories
- Lifespan Cancer Institute and Dana-Farber Cancer Institute
- The Joint Program in Cancer Biology
- Cancer Program Annual Reports
- Cancer Data Registry
- Cancer Symptoms Not to Ignore
- In the News
- Giving to the Lifespan Cancer Institute
Lifespan Cancer Institute and Dana-Farber Cancer Institute
Working Together to Advance Cancer Treatment and Research
Dana-Farber Cancer Institute and the Lifespan Cancer Institute have created a strategic alliance to advance cancer treatment and research.
Dana-Farber and Lifespan Cancer Institute support the expansion of clinical trials, access for Lifespan physicians to cancer-specific disease expertise for complex cases, and the launch of a new program to coordinate the treatment of bone marrow transplant patients, with transplants provided in Boston at Dana-Farber/Brigham and Women's Cancer Center, and care surrounding the transplant provided at Lifespan Cancer Institute in Providence.
The two organizations share patient information through their respective cancer-specific electronic health record systems and will use the same clinical trials management platform, resulting in better care coordination.
A top priority of Dana-Farber and Lifespan Cancer Institute’s work together is the ability to offer the latest and most advanced clinical trials to patients in Rhode Island. While many of these trials are developed at and provided by Dana-Farber, there are also opportunities for clinical trials developed at the Lifespan Cancer Institute to be offered to Dana-Farber patients. Increasing access to diverse patient populations is a common goal to help accelerate the development of new therapies.
Other areas we are exploring include genomics and precision medicine, cancer disparities, innovation in the delivery of cancer care, and potential synergies in basic research. The two organizations have collaborated on a multi-site grant application for genomics with a health disparities component.